Atlas Genetics
Molecular diagnostics at Point-of-Care
Total raised
€32M
€31,900,000
Funding rounds
1
Investors
7
distinct backers
Active since
2016-12
latest 2016-12
Funding by year
EUR raised per yearSignals
High confidenceRaise-next likelihood19
base rate 53% for Series D+
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 rounds| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2017-01-01 | Series D+ | €32M | BB Biotech Ventures,Global Life Science Ventures,Johnson & Johnson Innovation,Novartis Venture Fund,RMI Partners,Technology Venture Partners+1 more | View deal → |